Suzhou Medicalsystem Technology Co.Ltd(603990) announced that the company plans to issue non-public shares to Haoxiang holdings at a price of 14.44 yuan / share (if the profit distribution and capital reserve conversion to share capital scheme in 2021 is completed, the price of this non-public offering will be adjusted to 11.11 yuan / share accordingly). The total amount of capital raised does not exceed 23892927956 yuan. After deducting relevant issuance expenses, it will be used to supplement working capital and repay interest bearing loans. After the issuance, the controlling shareholder of the listed company was changed from Weng Kang to Haoxiang holding, and the actual controller was changed from Weng Kang to the state owned assets supervision and Administration Commission of Anzhou District, Mianyang City.
The company announced on the same day that on May 23, 2022, the controlling shareholder Weng Kang and the persons acting in concert Yan huanghong, Wang Jianhua, the shareholder Fu Hong and Haoxiang holdings signed the share transfer agreement. According to the agreement, Weng Kang, Yan huanghong, Wang Jianhua and Fu Hong plan to transfer a total of 12631936 shares of the company’s shares held by them to Haoxiang holdings at a transfer price of 26.6 yuan / share and a total transfer price of 33600949760 yuan, accounting for 7.63% of the total share capital of the company.
